2OZA

MICROVAST HOLD. DL-0001

Consumer Cyclical · EUR · F

2OZA

Price

€1.236

+6.74%

Cap

€707.23M

Earnings

30d Trend

-28.0%

2OZA
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

122% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level85
Quality56
Momentum11
Technical40
Fundamentals50

Raw weighted: 37×Macro 0.99 (1%)=37

RISK

85/100
90d Volatility
121.5%High
ATR %
10.6%High daily moves
Max Drawdown (1Y)
-81.3%Volatile

QUALITY

56/100
ROE (avg)
-7.1%Negative
Piotroski F-Score
5/9Average
Debt/Equity
0.03Low leverage
Accruals
-10.5%Cash earnings
Interest Coverage
4.3xAdequate

MOMENTUM

11/100
12-1M Momentum
-46.1%Strong downtrend
6-1M Momentum
-42.9%Negative
1M Return
-11.6%Sharp decline

TECHNICAL

40/100
RSI (14)
49.5Neutral
Price vs SMA200
-45.8%Bearish trend
MACD
0.00Bearish momentum
Bollinger Band
48%Mid-range
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.092Noisy/choppy

FUNDAMENTALS

50/100
EV/EBIT
79.5Expensive
P/FCF
11.5Cheap
P/S
1.5Cheap

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months38
3-12 months20
1-5+ years40

Weak long-term thesis — fundamentals do not support a buy-and-hold position

BRAIN47'S ASSESSMENT

I rate MICROVAST HOLD. DL-0001 at 37/100 — a WEAK reading on the Brain47 Signal. The strongest factor is quality at 56/100. I classify this as a speculative position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-11.6%

3 MONTHS

-28.6%

12 MONTHS

-57.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Weak long-term thesis — fundamentals do not support a buy-and-hold position. Quality (56) and Fundamentals (50) are the primary strengths. I note that momentum is the weakest area at 11/100 — this warrants monitoring. Historical volatility is elevated at 122%. I classify this as a speculative position — elevated volatility at 122% and smaller market cap define the opportunity.

speculativeScore: 37/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.